Medications for OCD
What medications are used for OCD, why the doses run higher than in depression, and where clomipramine and augmentation fit.
First-line options
SSRIs
The four SSRIs with FDA approval for OCD are fluoxetine, sertraline, fluvoxamine, and paroxetine. All work. Citalopram, escitalopram, and other SSRIs are used off-label with similar efficacy in trials.
Fluoxetine at 20 to 80 mg. FDA-approved for OCD in adults and children. Long half-life is forgiving of missed doses. Doses at the high end (60 to 80 mg) are common in OCD, higher than typical depression dosing.
Sertraline at 50 to 200 mg. FDA-approved for OCD in adults and children. Often the practical default because it's cheap, tolerable, and has broad anxiety indications.
Fluvoxamine at 100 to 300 mg (divided). FDA-approved for OCD. Strong CYP1A2 inhibitor with more drug interactions than the other SSRIs, which limits use. Immediate-release requires twice-daily dosing.
Paroxetine at 20 to 60 mg. FDA-approved for OCD. Works, but the side effect and discontinuation profile makes it less popular first-line.
Escitalopram at 10 to 40 mg is used off-label for OCD and tends to be reasonably tolerable. FDA-approved dose caps at 20 mg but higher doses have been used in OCD off-label with some caution about QT.
Citalopram has similar off-label use. The QT dose cap (40 mg most adults, 20 mg older adults) limits headroom in OCD where higher doses are often needed.
For the class picture, see the SSRI class page.
Why higher doses matter
OCD often requires doses at or above the top of the FDA range. This is one of the diagnostic-relevant differences between OCD and depression treatment. Titrating up as tolerated and giving the higher dose a fair trial (10 to 12 weeks) is standard. Stopping at typical depression doses without full response is a common miss.
Clomipramine
Clomipramine at 100 to 250 mg is a TCA with strong serotonergic activity. FDA-approved for OCD, and in some meta-analyses it matches or slightly beats SSRIs in efficacy. The tradeoffs are the TCA side effect profile: anticholinergic burden (dry mouth, constipation, blurred vision, urinary retention), orthostatic hypotension, weight gain, sedation, cardiac risk in overdose, and seizure risk at higher doses. Baseline ECG is reasonable.
Clomipramine sits behind SSRIs in current practice because of tolerability, but it's still a legitimate first-line option for patients who prefer or need it. It's often used in SSRI-refractory cases.
Exposure and response prevention (ERP)
ERP is the therapy anchor for OCD and has effect sizes larger than medication in most trials. Combined treatment (SSRI plus ERP) outperforms either alone for moderate-to-severe OCD. For patients unable to engage in ERP initially, medication is a reasonable starting point with the goal of adding ERP when tolerable.
Second-line and augmentation
Atypical antipsychotic augmentation
When an SSRI at maximum tolerated dose for 10 to 12 weeks has produced partial response, adding a low-dose atypical antipsychotic is well-supported.
Risperidone at 0.5 to 2 mg has the most trial evidence for OCD augmentation. Effective in some patients, particularly those with tic-related OCD.
Aripiprazole at 5 to 15 mg has evidence as OCD augmentation, with a more favorable metabolic profile than risperidone.
Haloperidol at low doses (0.5 to 2 mg) has evidence in tic-related OCD.
Response to augmentation is typically seen within 4 to 8 weeks. Metabolic monitoring is standard.
Combined SSRI and clomipramine
Combining an SSRI (usually one that isn't a strong CYP2D6 inhibitor) with low-dose clomipramine is used in refractory OCD. Requires careful monitoring for serotonin syndrome and cardiac effects. Fluvoxamine plus clomipramine, in particular, boosts clomipramine levels through CYP1A2 inhibition and requires level monitoring.
N-acetylcysteine (NAC)
NAC at 2400 to 3000 mg (divided) has small trials suggesting benefit as OCD augmentation, particularly for trichotillomania and other body-focused repetitive behaviors within the OC spectrum. Well-tolerated. OTC availability makes it easy to try.
Memantine
Memantine at 10 to 20 mg has small trials as OCD augmentation with mixed results.
Other agents
Glutamate-modulating agents (topiramate, riluzole, lamotrigine, ketamine) have varying levels of small evidence in OCD. Most remain experimental or reserved for severe refractory cases.
When to consider a different approach
Treatment-resistant OCD
Two adequate SSRI trials at high dose for 10 to 12 weeks without adequate response meets the working definition of treatment-resistant OCD. Options at that point include switching to clomipramine, augmenting with an atypical antipsychotic, combining SSRI plus clomipramine (with monitoring), intensifying ERP (residential or intensive outpatient programs), and considering neuromodulation.
Deep brain stimulation (DBS) has an FDA humanitarian device exemption for severe treatment-resistant OCD. Gamma knife capsulotomy is done at select centers. Transcranial magnetic stimulation (TMS) has FDA clearance for OCD (specifically deep TMS with the Brainsway device).
Comorbid tics or Tourette's
Tic-related OCD responds better to atypical antipsychotic augmentation (risperidone, aripiprazole, haloperidol) than pure OCD does. Guanfacine or clonidine can also help both tics and hyperactivity.
Hoarding
Hoarding disorder is now a separate DSM-5 diagnosis and responds less well to SSRI monotherapy than OCD does. CBT specifically adapted for hoarding is the primary treatment.
Special considerations
Pediatric OCD
Sertraline and fluoxetine are FDA-approved for pediatric OCD. Fluvoxamine has approval in children and adolescents. CBT with ERP is the recommended first-line treatment in children. Medication is added for moderate-to-severe cases or when ERP alone isn't enough. Suicidality monitoring in the first weeks of SSRI treatment applies as it does for depression.
PANDAS/PANS (pediatric autoimmune neuropsychiatric disorders) are a separate consideration in children with abrupt-onset OCD; workup and immunomodulatory treatment may be considered.
Pregnancy
Untreated OCD in pregnancy has real consequences, and the postpartum period is a time of high symptom risk. Sertraline is the most-studied SSRI in pregnancy. Fluoxetine has extensive reproductive data. Paroxetine is generally avoided in the first trimester. Clomipramine has been used with some reproductive data. See the pregnancy safety reference.
Older adults
Escitalopram and sertraline at moderate doses are usually well-tolerated in older adults. Fluvoxamine's drug interactions limit use. Clomipramine is generally avoided because of anticholinergic burden and Beers Criteria concerns. See Beers Criteria for psychiatric medications.
Comorbid depression
SSRIs cover both. Doses at the OCD range (higher end) also treat depression. Bupropion doesn't work for OCD and can worsen anxiety, so it's not the choice when OCD is dominant.
Comorbid anxiety
SSRIs and clomipramine both cover generalized anxiety. Doses effective for OCD are typically effective for anxiety too. Benzodiazepines are usually avoided as chronic treatment because they can interfere with the extinction learning that ERP relies on.
Comorbid bipolar
Bipolar plus OCD is challenging. SSRIs at high doses in undiagnosed bipolar can trigger mania. A mood stabilizer on board first, then SSRI titrated cautiously. Screening for bipolar history matters. See medications for bipolar disorder.
What tips the choice
- Newly diagnosed OCD, no strong comorbidity signal: sertraline or fluoxetine. Titrate to high end of the range (sertraline 200 mg, fluoxetine 60 to 80 mg). 10 to 12 week trial before judging response.
- Prefer once-daily dosing: fluoxetine (very long half-life) or sertraline.
- Comorbid depression: SSRI covers both.
- Comorbid anxiety: SSRI covers both.
- Tic-related OCD: SSRI plus low-dose risperidone or aripiprazole is a common combination.
- SSRI partial response after adequate trial: augment with risperidone or aripiprazole, or switch to a different SSRI or to clomipramine.
- Two SSRI failures: clomipramine trial. Add atypical augmentation.
- Refractory to all first-line and second-line: intensive ERP program, TMS (Brainsway), or specialty referral for DBS or gamma knife capsulotomy in severe cases.
- Pediatric OCD: CBT with ERP first-line, add sertraline or fluoxetine for moderate-to-severe cases.
- Pregnancy: sertraline or fluoxetine with reproductive safety context.
- Older adult: escitalopram or sertraline at moderate doses.
- ERP tolerable: therapy is central, medication supports.
- ERP not tolerable now: medication as starting point, therapy added when tolerable.
Common questions
Why do OCD doses run higher than depression doses? In trials, OCD responds better at the higher end of the SSRI dose range than at typical depression doses. The reasons aren't fully known, but the pattern is consistent enough that most guidelines recommend titrating to high dose before judging response as inadequate. Sertraline 200 mg, fluoxetine 60 to 80 mg, and fluvoxamine 200 to 300 mg are common endpoints.
How long before I know if the medication is working? OCD response is slower than depression response. Full effect can take 10 to 12 weeks at a therapeutic dose. Stopping at 4 to 6 weeks because nothing has changed is a common miss. Titrating up gradually and giving the higher dose a fair trial is the standard.
Do I need therapy on top of the medication? For moderate-to-severe OCD, yes, ERP is the therapy with the strongest evidence, and combined treatment outperforms either alone. Medication alone helps but rarely produces the same durable improvement as combined treatment. ERP is difficult and requires trained therapists; specialty referral is often needed.
What if I can't do exposure therapy? ERP is challenging and not always immediately tolerable. Medication can reduce OCD severity to the point where ERP becomes accessible. Some patients benefit from CBT variants that emphasize cognitive restructuring before formal ERP. Acceptance and commitment therapy (ACT) is being studied in OCD as an adjunct or alternative.
What about brain stimulation for severe OCD? Deep transcranial magnetic stimulation (dTMS with the Brainsway device) is FDA-cleared for OCD. Deep brain stimulation has an FDA humanitarian device exemption for severe treatment-resistant OCD, done at specialty centers. Gamma knife capsulotomy is another neurosurgical option for the most severe refractory cases. These are reserved for patients who have failed multiple medication trials, ERP, and augmentation.
Sources
This guide draws on current prescribing information, treatment guidelines, and public health references. It is reviewed for clinical accuracy and updated as guidance changes.
- American Psychiatric Association. Practice guideline for the treatment of patients with OCD.
- International OCD Foundation. Treatment resources.
- Skapinakis P et al. Pharmacological and psychotherapeutic interventions for OCD: systematic review and network meta-analysis.
- National Institute of Mental Health. Obsessive-compulsive disorder.
THE KNOWLEDGE PATH
Walk this topic outward.
- GUIDE Medications for OCD (current)
- CLASS SSRIs
- MEDICATION Sertraline (Zoloft)
- CONDITION Major Depressive Disorder (on Shrinkopedia)
- CARE Consider depression evaluation at shrinkMD
The Knowledge Path is a curated walk. Every step is one decision away from the next.
Managing a medication needs a prescriber
Any psychiatric medication has to be started and adjusted by a clinician who can follow you over time. If you don't have a prescriber, our guides section explains the options, including in-person care and telepsychiatry, and how to choose between them.